Total Payments
$12,770
2024 Payments
$1,916
Companies
28
Transactions
366
Medicare Patients
1,448
Medicare Billing
$161,549
Payment Breakdown by Category
Food & Beverage$9,664 (75.7%)
Travel$3,007 (23.5%)
Education$99.11 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,664 | 354 | 75.7% |
| Travel and Lodging | $3,007 | 5 | 23.5% |
| Education | $99.11 | 7 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $2,421 | 7 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $1,474 | 71 | $0 (2024) |
| Boston Scientific Corporation | $1,178 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,117 | 45 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,055 | 55 | $0 (2024) |
| Merck Sharp & Dohme LLC | $940.43 | 31 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $481.40 | 24 | $0 (2024) |
| Amgen Inc. | $465.15 | 6 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $461.90 | 15 | $0 (2019) |
| PFIZER INC. | $440.88 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,916 | 64 | Merck Sharp & Dohme LLC ($299.47) |
| 2023 | $1,353 | 53 | Merck Sharp & Dohme LLC ($298.79) |
| 2022 | $1,477 | 60 | Merck Sharp & Dohme LLC ($312.06) |
| 2021 | $706.89 | 38 | Janssen Pharmaceuticals, Inc ($240.28) |
| 2020 | $1,100 | 47 | Amarin Pharma Inc. ($317.20) |
| 2019 | $982.61 | 40 | Novartis Pharmaceuticals Corporation ($267.46) |
| 2018 | $797.57 | 25 | Novartis Pharmaceuticals Corporation ($530.80) |
| 2017 | $4,436 | 39 | Medtronic Vascular, Inc. ($2,389) |
All Payment Transactions
366 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $28.04 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/07/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.02 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Cardio-renal | ||||||
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $19.62 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: DIABETES | ||||||
| 08/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $77.13 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 373 | 522 | $116,187 | $38,710 |
| 2022 | 9 | 364 | 526 | $126,912 | $41,529 |
| 2021 | 8 | 372 | 545 | $120,295 | $42,408 |
| 2020 | 8 | 339 | 504 | $114,133 | $38,902 |
Total Patients
1,448
Total Services
2,097
Medicare Billing
$161,549
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 103 | $21,335 | $10,468 | 49.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 126 | $19,782 | $8,548 | 43.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 48 | 49 | $31,850 | $7,831 | 24.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 32 | $12,480 | $3,564 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $7,560 | $3,027 | 40.0% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 28 | 28 | $8,400 | $1,475 | 17.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 80 | 124 | $9,300 | $1,464 | 15.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 22 | 22 | $3,520 | $1,291 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 14 | $1,960 | $1,042 | 53.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 106 | $21,730 | $11,312 | 52.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 57 | 58 | $37,700 | $9,884 | 26.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 111 | $17,427 | $6,547 | 37.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 28 | 28 | $10,920 | $3,125 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $7,245 | $2,996 | 41.3% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2022 | 34 | 34 | $10,200 | $2,032 | 19.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 11 | 11 | $7,700 | $1,779 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 22 | $3,080 | $1,702 | 55.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 72 | 122 | $9,150 | $1,488 | 16.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 11 | 11 | $1,760 | $664.90 | 37.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 112 | $22,960 | $11,657 | 50.8% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 51 | 52 | $33,800 | $9,770 | 28.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 48 | 110 | $17,270 | $6,779 | 39.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 41 | $5,740 | $3,221 | 56.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 27 | 27 | $10,530 | $3,194 | 30.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $6,930 | $2,770 | 40.0% |
About Dr. Tanvir Hussain, M.D
Dr. Tanvir Hussain, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891898797.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tanvir Hussain, M.D has received a total of $12,770 in payments from pharmaceutical and medical device companies, with $1,916 received in 2024. These payments were reported across 366 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($9,664).
As a Medicare-enrolled provider, Hussain has provided services to 1,448 Medicare beneficiaries, totaling 2,097 services with total Medicare billing of $161,549. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Pasadena, CA
- Active Since 09/06/2006
- Last Updated 10/17/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891898797
Products in Payments
- Advisa (Device) $2,479
- ENTRESTO (Drug) $1,233
- XARELTO (Drug) $1,117
- LifeVest (Device) $1,055
- GENERAL - THERAPIES (Device) $963.69
- VERQUVO (Drug) $940.43
- ELIQUIS (Drug) $531.06
- Repatha (Biological) $465.15
- Vascepa (Drug) $397.75
- PRALUENT (Drug) $250.71
- LEQVIO (Drug) $241.05
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $218.52
- Kerendia (Drug) $216.32
- CAMZYOS (Drug) $197.49
- VYNDAQEL (Drug) $193.73
- Inpefa (Drug) $184.61
- Reveal LINQ (Device) $173.11
- JARDIANCE (Drug) $172.35
- FARXIGA (Drug) $165.22
- GENERAL - TACHY (Device) $137.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Internal Medicine $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882